Accessibility: Skip TopNav
CB-011
CB-011 is a genome-edited allogeneic anti-BCMA CAR-T cell therapy with immune cloaking.
Format
PNG
Quelle:
Caribou Biosciences, Inc.
Downloads
Originalgröße
Groß
Mittel
Klein